Effect of regional and systemic fluorinated pyrimidine chemotherapy on quality of life in colorectal liver metastasis patients

Journal of Clinical Oncology

Volumn 15, Issue 5, 1997, Pages 2022-2029

  Earlam, S ^a   Glover, C ^a   Davies, M ^a   Fordy, C ^a   Allen Mersh, T G ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIEMETIC AGENT; CHLORHEXIDINE GLUCONATE; CORTICOSTEROID; FLOXURIDINE; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; FOLINIC ACID; PYRIDOXINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER METASTASIS; LIVER TOXICITY; MAJOR CLINICAL STUDY; NAUSEA; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; STOMATITIS;

EID: 0030900125     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.5.2022     Document Type: Article

References (30)

1. Allen-Mersh TG: Improving survival after large bowel cancer: Surgeons should look for the occult. Leader. Br Med J 303:595-596, 1991
2. Allen-Mersh TG: Colorectal liver metastases: Is no treatment still best? J R Soc Med 82:746-747, 1989 (editorial)
3. Nordic Gastrointestinal Tumor Adjuvant Therapy Group: Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: A randomized trial. J Clin Oncol 10:904-911, 1992
4. Allen-Mersh TG, Earlam S, Fordy C, et al: Quality of life and survival with continuous hepatic artery floxuridine infusion for colorectal liver metastases. Lancet 344:1255-1260, 1994
5. Piedbois P, Buyse M, Kemeny N, et al: Reappraisal of hepatic arterial infusion in the treatment of non-resectable liver metastases from colorectal cancer. J Nat Cancer Inst 88:252-258, 1996
6. O'Neil WM: Pain in malignant disease. Prescr J 33:250-258, 1993
7. Cunningham D, Zalcberg JR, Rath U, et al: Tomudex (ZD1694): Results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia. Eur J Cancer 12:1945-1954, 1995
8. Arbuck SG: Overview of clinical trials using 5FU and leucovorin for treatment of colorectal cancer. Cancer 63:1036-1044, 1989
9. Hohn DC, Rayner AA, Economou JS, et al: Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion. Cancer 57:465-470, 1986
10. World Health Organization: WHO Handbook for Reporting Results of Cancer Treatment. Geneva, Switzerland, WHO Offset Publications no. 48, 1979
11. Comandone A, Bretti S, La Grotta G, et al: Palmer-planter erythrodysestasia syndrome associated with 5 FU treatment. Anticancer Res 13:1781-1783, 1993
12. Vukelja J, Lombardo A, James D, et al: Pyridoxine for the palmar-plantar erythrodysesthesia syndrome. Ann Intern Med 111:688-689, 1989
13. Burke D, Earlam S, Fordy C, et al: Effect of aberrant hepatic arterial anatomy on tumour response to regional floxuridine infusion for colorectal liver metastases. Br J Surg 82:1098-1100, 1995
14. DeHaes IC, Van Knippenberg FC, Neijt JP: Measuring psychological and physical distress in cancer patients: Structure and application of the Rotterdam Symptom Checklist. Br J Cancer 62:1034-1038, 1990
15. Bergner M, Bobbitt RA, Carter WB, et al: The Sickness Impact File: Development and final revision of a health status measure. Medcare 19:787-905, 1981
16. Zigmund AS, Snaith RP: The hospital anxiety and depression scale. Acta Psych Scand 67:361-370, 1983
17. Dworkin MJ, Burke D, Earlam S, et al: Measurement of response to treatment in colorectal liver metastases. Br J Cancer 71:873-876, 1995
18. Zwinderman AH: Statistical analysis of longitudinal quality of life data with missing values. Qual Life Res 1:219-224, 1992
19. Langley R: Spearman's correlation test, in Practical Statistics Simply Explained (ed 2). London, United Kingdom, Pan Books, London, 1979, pp 199-211
20. Dixon W: T Test, in BMDP Statistical Software Manual, Release 7. Los Angeles, CA, University of California, 1992, pp 155-174
21. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomised clinical trials requiring prolonged observations. Br J Cancer 35:1-39, 1977
22. Kaplan EL, Meier P: Nonparametric estimations for incomplete observations. J Am Stat Assoc 53:457-468, 1958
23. Langley R: Spearman's correlation test, in Practical Statistics Simply Explained (ed 2). London, United Kingdom, Pan Books, 1979, pp 199-211
24. Murray GD: Statistical aspects of research methodology. Br J Surg 78:777-781, 1991
25. Advanced Colorectal Cancer Meta-analysis Project: Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate. J Clin Oncol 10:896-903, 1992
26. Burke D, Fordy C, Earlam S, et al: Hepatic arterial cannulation for regional chemotherapy is safe in patients with < 1 litre liver metastasis volume. Br J Cancer (in press)
27. Fordy C, Burke D, Earlam S, et al: Treatment interruptions and complications with two continuous hepatic artery floxuridine infusion systems in colorectal liver metastases. Br J Cancer 72:1023-1025, 1995
28. Ensminger WD, Rosowsky A, Raso V, et al: A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2-deoxyuridine and 5 fluorouracil. Cancer Res 38:3784-3792, 1978
29. Freedman L: Bayesian statistical methods. Br Med J 313:569-570, 1996
30. Fraser SCA, Ramirez AJ, Ebbs SR, et al: A daily diary for QoL measurement in advanced breast cancer trials. Br J Cancer 67:341-346, 1993